FET

DRUG2 trials

Sponsors

Universitaetsklinikum Aachen AöR, Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Conditions

ACTH-dependent hypercortisolismPatients with newly diagnosed cerebral gliomasrecurrent cerebral gliomas and brain metastases.

Phase 2

Comparison of 18F-Fluciclovine PET versus 18F-Fluoroethyltyrosine PET in patients with newly diagnosed cerebral gliomas, recurrent cerebral gliomas and brain metastases – an open label single centre single arm prospective basket trial

Active, not recruitingCTIS2023-507786-26-00

Universitaetsklinikum Aachen AöRPatients with newly diagnosed cerebral gliomas, recurrent cerebral gliomas and brain metastases.

Start: 2024-08-14Target: 80Updated: 2025-08-26

Phase 3

Use of [18F]FET PET-MRI to improve detection of pituitary adenomas in Cushing’s disease

Not yet recruitingCTIS2024-518908-46-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)ACTH-dependent hypercortisolism

Target: 30Updated: 2025-07-23